EDEN RESEARCH PLC

1. EDEN RESEARCH PLC 2003-11-27 → present
2. XIMED GROUP PLC 1998-07-27 → 2003-11-27
3. ENERGISER PLC 1995-06-22 → 1998-07-27

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

PKF Littlejohn LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Directors have, at the time of approving the financial statements, a reasonable expectation that the Group and Company have adequate resources to continue in operational existence for at least 12 months from the approval of the financial statements, and the financial statements have been prepared on a going concern basis which contemplates the realisation of assets and the settlement of liabilities in the ordinary course of business.”

Group structure

1. EDEN RESEARCH PLC · parent
   1. TerpeneTech Limited (UK) 50% · Republic of Ireland · Sale of biocide products
   2. Eden Research Europe Limited 100% · Republic of Ireland · Dormant

Significant events

• “Total revenue for the year was up 34% to £4.3m (2023: £3.2m). In particular, product sales, driven by Cedroz and Mevalone®, increased by 38% to £3.6m (2023: £2.6m). Operating loss for the period was £2.2m (2023: £1.9m loss), after non-cash amortisation of intangible assets and share-based payment expensing (£0.6m (2023: £0.7m)). Loss before tax was £2.2m (2023: £6.9m) after non-cash impairment of intangible assets of £nil (2023: £5.0m), and statutory operating loss was £2.2m (2023: £1.9m). Cash position at the year-end was £3.7m (2023: £7.4m).”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

6

last 12 months

Capital events

2

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +34.8%

  £3,192,027 → £4,302,603

• Cash

  -50.4%

  £7,413,107 → £3,674,796

• Net assets

  -12.6%

  £13,545,797 → £11,837,586

• Employees

  +21.1%

  19 → 23

• Operating profit

  -17.1%

  -£1,866,691 → -£2,186,279

• Profit before tax

  +68.5%

  -£6,920,262 → -£2,180,147

• Wages

  +6.5%

  £1,569,096 → £1,670,854

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers